(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers.

The U.S. Food and Drug Administration has ordered a software recall for a type of ventilator, for fear of "serious injuries or death."The ventilators—the Philips Respironics, Inc. Trilogy EVO ...

Philips Respironics Issues Additional Usage Instructions for Trilogy Evo Ventilators Related to Use of In-Line Nebulizers. Oct. 6, 2024.

Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.

Some products that were modified in an attempt to resolve the issue have been recalled as well. Specifically, certain reworked Philips Respironics Trilogy 100/200 Ventilators, as the FDA has asked ...

R espiratory medical device firm Philips has been hit with yet another Class I recall by the US Food and Drug Administration (FDA) after it was found that the software in some of its ventilators ...

In August 2023, Philips recalled Respironics Trilogy Evo, Evo O2, EV300, and Evo Universal ventilators after detecting dust and dirt from the environment in the air path of some devices.

The Dutch company is recalling reworked Respironics Trilogy 100, Trilogy 200, and Garbin Plus ventilators due to potential for silicone foam adhesion failure and residual PE‐PUR foam debris.

Benzinga - by Zacks, Benzinga Contributor. Koninklijke Philips (NYSE: PHG) notified its customers about a possible power malfunction in its Trilogy Evo continuous ventilators and initiated a software ...

Two major factors explain the softness in Royal Philips' 2022 results: the ever-expanding recall of its subsidiary Philips Respironics' ventilators and sleep apnea masks, ...